1. Home
  2. PROF vs PZC Comparison

PROF vs PZC Comparison

Compare PROF & PZC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • PZC
  • Stock Information
  • Founded
  • PROF N/A
  • PZC 2002
  • Country
  • PROF Canada
  • PZC United States
  • Employees
  • PROF N/A
  • PZC N/A
  • Industry
  • PROF Medical/Dental Instruments
  • PZC Investment Managers
  • Sector
  • PROF Health Care
  • PZC Finance
  • Exchange
  • PROF Nasdaq
  • PZC Nasdaq
  • Market Cap
  • PROF 186.3M
  • PZC 168.0M
  • IPO Year
  • PROF N/A
  • PZC N/A
  • Fundamental
  • Price
  • PROF $7.55
  • PZC $7.11
  • Analyst Decision
  • PROF Strong Buy
  • PZC
  • Analyst Count
  • PROF 2
  • PZC 0
  • Target Price
  • PROF $11.40
  • PZC N/A
  • AVG Volume (30 Days)
  • PROF 45.3K
  • PZC 48.2K
  • Earning Date
  • PROF 11-07-2024
  • PZC 01-01-0001
  • Dividend Yield
  • PROF N/A
  • PZC 4.68%
  • EPS Growth
  • PROF N/A
  • PZC N/A
  • EPS
  • PROF N/A
  • PZC N/A
  • Revenue
  • PROF $8,984,000.00
  • PZC N/A
  • Revenue This Year
  • PROF $56.11
  • PZC N/A
  • Revenue Next Year
  • PROF $171.96
  • PZC N/A
  • P/E Ratio
  • PROF N/A
  • PZC N/A
  • Revenue Growth
  • PROF 39.35
  • PZC N/A
  • 52 Week Low
  • PROF $7.11
  • PZC $6.30
  • 52 Week High
  • PROF $11.42
  • PZC $8.20
  • Technical
  • Relative Strength Index (RSI)
  • PROF 44.16
  • PZC 39.80
  • Support Level
  • PROF $7.40
  • PZC $7.03
  • Resistance Level
  • PROF $8.22
  • PZC $7.12
  • Average True Range (ATR)
  • PROF 0.50
  • PZC 0.06
  • MACD
  • PROF -0.06
  • PZC -0.00
  • Stochastic Oscillator
  • PROF 8.32
  • PZC 32.00

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About PZC PIMCO California Municipal Income Fund III of Beneficial Interest

PIMCO CA Muni Income Fund III operates as a closed-end management investment company. The investment objective of the fund is to seek to provide current income exempt from federal and California income tax. Its portfolio of investments includes investment in different sectors such as education, healthcare, industrial and others.

Share on Social Networks: